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I. INTRODUCTION 
 
“Food safety doesn't begin at the grocery store or in the kitchen. It begins on 
the farm.” (USDA, 2006) 
Within Europe, concerns about food have largely shifted from ensuring an 
adequate supply of products towards food safety, animal and plant welfare, 
and traceability (EUROSTAT, 2008). To provide safe and healthy food the EU 
has adopted an integrated approach, from the farm to the fork, to ensure food 
safety and quality on each level of the food chain. “From farm to fork” aims at 
linking the entire chain of food production from raising animals and processing 
its products up to the retail level, assuring safe food being delivered to the 
consumer. This approach calls for risk assessment and surveillance on every 
level of the food chain as well as communication and interaction among all 
participants. At the level of primary production animal health and welfare are 
the main keys to public health, as they are linked to each other: Healthy and 
well-kept animals will produce healthy and safe products with, e.g. a highly 
reduced need for antibiotic treatment. In addition to healthy animals, 
epidemiologic surveillance systems on farms are necessary to prevent 
transmission of potential pathogens and resistance mechanisms via the food 
chain (FVE, 2012). Therefore, pathogen prevalence monitoring, as well as 
resistance monitoring, are an essential basis for risk assessment and rational 
discussions leading to actions that secure animal and public health equally. 
 
Furthermore, resistance to clinically used antimicrobials is not a phenomenon 
that has come up during the last few years; it already emerged shortly after the 
first introduction of penicillin into clinical use in the 1940s. The number of 
resistant bacteria was low in these early days and therefore, was not 
considered as a significant problem. However, after the clinical introduction of 
new antimicrobial drugs, resistance could be detected shortly afterwards not 
only in pathogenic, but also in commensal bacteria (BARBOSA & LEVY, 2000; 
SCHWARZ et al., 2006).  
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The objective of this work was on one side to study the occurrence of 
extended-spectrum β-lactamase-producing Escherichia coli on dairy and beef 
cattle farms in Bavaria and to elucidate possible risk factors for their spread. It 
was conducted within the RESET joint research project (www.reset-
verbund.de). This interdisciplinary research project, comprising federal and 
regional authorities, as well as universities, was funded by the Ministry of 
Education and Research (Bundesministerium für Bildung und Forschung) and 
collects data on the epidemiology and genetics of ESBL E. coli in different 
fields of research (veterinary and human medicine, the environment and food) 
to determine the origin, way of transmission and the risk for humans being 
exposed to them.  
On the other side the occurrence of potentially foodborne pathogens, namely 
Clostridium difficile, Clostridium botulinum and Yersinia enterocolitica was 
assessed in healthy cattle of different ages and production types to estimate 
the potential risk of transmitting these bacteria via the food chain. There is a 
paucity of studies concerning prevalence rates of both parts of this work in 
Germany and other European countries, particularly on a country-wide or 
regional scale. This would be necessary to identify dynamics and risk factors 
for transmitting potentially zoonotic pathogens and resistance mechanisms 
from animals to humans. 
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II.  LITERATURE OVERVIEW 
 
1. Extended-spectrum β-lactamase-producing  
 Escherichia coli 
 
1.1. Escherichia coli – general information 
Escherichia (E.) coli is a gram-negative, rod-shaped bacterium, 2 to 6 µm in 
length belonging to the family Enterobacteriaceae. Most strains are motile due 
to peritrichous flagella and fimbriae. E. coli are oxidase-negative, catalase-
positive, non-spore forming facultative anaerobes which ferment lactose and 
produce indole (SONGER et al., 2005). However, there exist some strains that 
do not ferment lactose. E. coli grow well on non-selective media and certain 
strains show hemolytic activity on blood agar. On MacConkey agar E. coli 
grow as they are not inhibited by the bile salts in the medium. Because of the 
acid production from lactose fermentation colonies on MacConkey agar and 
the surrounding medium are pink (QUINN et al., 2001). To distinguish E. coli 
from other members of the Enterobacteriaceae family the growth 
characteristics and biochemical reactions as described above are very 
important. Furthermore, E. coli isolates and isolates of Enterobacteriaceae in 
general are serotyped using somatic (O), flagellar (H) and capsular (K) 
antigens. Somatic antigens are lipopolysaccharides which are located at the 
surface of the cell wall. Flagellar antigens are proteins and capsular antigens 
consist of polysaccharides (QUINN et al., 2001). 
Shortly after birth the intestinal tract of humans and a multitude of animals is 
colonized by E. coli which are part of the normal flora of the large intestine. 
However, not all E. coli strains are commensal and non-pathogenic: 
Pathogenic strains possess virulence factors including capsular 
polysaccharides which interfere with the complement system, fimbrial 
adhesins, intimin (another adhesin), enterotoxins, cytotoxic necrotizing factors, 
cytolethal distending factors and hemolysin (QUINN et al., 2001).  
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Pathogenic E. coli can be categorized into pathotypes: Six pathotypes are 
associated with diarrhea and collectively are referred to as diarrheagenic E. 
coli: 
- Enterohemorrhagic E. coli (EHEC)  
- Enterotoxigenic E. coli (ETEC) 
- Enteropathogenic E. coli (EPEC) 
- Enteroaggregative E. coli (EAEC) 
- Enteroinvasive E. coli (EIEC) 
- Diffusely adherent E. coli (DAEC)  
Besides all six pathotypes, EHEC is one of the most important ones and 
commonly associated with foodborne outbreaks (CDC, 2012). 
 
 
1.2. Extended-spectrum β-lactamase 
 
Extended-spectrum β-lactamases (ESBLs) are enzymes that are able to 
hydrolyze nearly all β-lactam antibiotics, such as penicillins, 
oxyminocephalosporins, monobactams and cephalosporins up to generation 3 
and 4, but usually not carbapenems and cephamycins. They are commonly 
inhibited by β-lactamase inhibitors as clavulanic acid, sulbactam and 
tazobactam. ESBLs are distributed worldwide and have been detected in 
various bacteria belonging to the family Enterobacteriaceae as Klebsiella 
pneumoniae, E. coli, Proteus mirabilis and Salmonella species. The enzymes 
are plasmid-encoded which facilitates gene transfer between bacteria from the 
same species or even family and therefore, fast and efficient spread of 
resistance (BONNET, 2004). The most commonly found ESBLs harbor genes 
belonging to the TEM, SHV and CTX-M families. 
 
II. Literature Overview 
 
5 
 
Classification 
 
1.2.1.1. Ambler/Bush classification 
 
β-lactamases are classified into four classes (Ambler class A-D) with regard to 
their molecular structure: class A, C and D containing serine β-lactamases and 
class B metallo-β-lactamases. They are further divided into four groups (Bush-
Jacoby group 1-4) and several subgroups defined by their substrate and 
inhibitor profiles (BUSH & JACOBY, 2010): 
 
Group   1:  Cephalosporinases that are not well inhibited by clavulanic  
  acid 
Group 2:  Penicillinases that are generally inhibited by active-site  
  directed β-lactamase inhibitors  
Group 2be: Penicillinases that have extended spectrum of activity 
Group  3:  Metallo-β-lactamases that are poorly inhibited by all classical   
  β-lactamase inhibitors except EDTA 
Group  4: Are omitted in the present scheme as they have been 
characterized incompletely. 
 
TABLE 1. Classification schemes for bacterial β-lactamases from BUSH & 
JACOBY (2010). 
Bush-Jacoby 
group 
Ambler 
Class 
Distinctive 
substrate(s) 
Inhibited 
by CA1 
or TZB2 
Representative 
enzymes 
1 C Cephalosporins No 
CMY-2, FOX-1, MIR-
1 
1e C Cephalosporins No GC1, CMY-37 
2a A Penicillins Yes PC1 
2b A 
Penicillins, early 
cephalosporins 
Yes 
TEM-1, TEM-2, SHV-
1 
2be A 
Extended-spectrum 
cephalosporins, 
monobactams 
Yes 
TEM-3, SHV-2, CTX-
M-15 
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TABLE 1. Classification schemes for bacterial β-lactamases from BUSH & 
JACOBY (2010). 
Bush-Jacoby 
group 
Ambler 
Class 
Distinctive 
substrate(s) 
Inhibited 
by CA1 
or TZB2 
Representative 
enzymes 
2br A Penicillins No TEM-30, SHV-10 
2ber A 
Extended-spectrum 
cephalosporins, 
monobactams 
No TEM-50 
2c A Carbenicillin Yes PSE-1, CARB-3 
2ce A 
Carbenicillin, 
cefepime 
Yes RTG-4 
2d D Cloxacillin Variable OXA-1, OXA-10 
2de D  
Extended-spectrum 
cephalosporins 
Variable OXA-11, OXA-15 
2df D Carbapenems Variable OXA-23, OXA-48 
2e A  
Extended-spectrum 
cephalosporins 
Yes CepA 
2f A Carbapenems Variable KPC-2, IMI-1, SME-1 
3a B (B1) Carbapenems No IMP-1, VIM-1, CcrA, 
IND-1 
3b B (B2) Carbapenems No CphA, Sfh-1 
NI3 4 Unknown   
1CA: clavulanic acid;  
2TZB: tazobactam; 
3NI: not included. 
 
Common ESBLs as TEM, SHV and CTX-M belong to Ambler Class A and 
Bush-Jacoby group 2be. Chromosomal- or plasmid-encoded AmpC β-
lactamases (see 1.2.1.5) are classified as Ambler class C and Bush-Jacoby 
group 1 and OXA-type ESBLs belong to Ambler Class D (Table 1). 
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1.2.1.2. TEM, SHV 
 
Broad-spectrum TEM β-lactamases were biochemically characterized in 1966 
on a strain isolated from a patient in Greece. This β-lactamase was plasmid-
mediated and able to hydrolyze ampicillin and related antimicrobials as 
piperacillin and carbenicillin. Due to point mutation TEM ESBLs evolved from 
the broad spectrum TEM-1 and -2 genes and are now able to hydrolyze 3rd 
and 4th generation cephalosporins (PFEIFER et al., 2010). The point mutations 
lead to 1-4 amino acid substitutions which induce changes in the active site of 
the enzyme reducing activity of 3rd and 4th generation cephalosporins and 
monobactams (WINOKUR et al., 2001). 
 
SHV ESBLs evolved in a similar way to TEM ESBLs by point mutation of the 
broad spectrum SHV-1 genes. SHV enzymes have evolved from chromosomal 
Klebsiella pneumoniae specific β-lactamases which were then mobilized onto 
plasmids (HAEGGMAN et al., 1997). 
 
Until the 2000s TEM and SHV-derived ESBLs were the predominant variants 
found most frequently in Klebsiella spp., but also in E. coli and other members 
of the Enterobacteriaceae family causing nosocomial infections (EFSA, 2011). 
 
1.2.1.3. OXA 
 
Most OXA-type ESBL enzymes (OXA-11,-14 and -16) derive from point 
mutations from the classical plasmid-mediated OXA-10 or from OXA-15 (OXA-
19 and -28) which are resistant to penicillins and 3rd generation cephalosporins 
(PFEIFER et al., 2010). These OXA-type ESBLs were predominantly found in 
Pseudomonas aeruginosa and only sporadically in Enterobacteriaceae 
(BRADFORD et al., 1999). However, a number of different class D OXA 
enzymes, as OXA-48, show resistance to carbapenems and were not only 
reported from P. aeruginosa but also from Enterobacteriaceae (PFEIFER et al., 
2010). 
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1.2.1.4. CTX-M 
 
Since the early 2000s CTX-M genes, which are genetically unrelated to TEM 
or SHV, emerged in human and animal isolates. Since then, CTX-M genes 
have emerged and spread worldwide with at present 148 molecular variants 
belonging to the CTX-M family (JACOBY, 2013). In 1989 BAUERNFEIND et al. 
(1990) first described a new extended-spectrum β-lactamase in an E. coli 
isolate from ear exudate of a newborn in Munich. It was plasmid-borne and 
able to hydrolyze cefotaxime at a higher rate than ceftazidime, which was 
unique compared to other ESBLs, and was therefore called CTX-M (CTX for 
cefotaximase, -M for Munich). However, newer CTX-M variants are able to 
hydrolyze ceftazidime as well due to mutations. 
 
CTX-M β-lactamases are divided into five clusters considering amino acid 
sequence similarities:  
CTX-M group 1:  main members are CTX-M-1,-3,-10,-11,-12,-15,-22,-23,-28,-
29,-30,-32,-33,-36,-54,-58,-66,-79,-116 
CTX-M group 2:  main members are CTX-M-2,-4,-6,-7,-20,-31,-35,-42,-44 
CTX-M group 8:  main members are CTX-M-8,-40,-63 
CTX-M group 9: main members are CTX-M-9,-13,-14,-16,-17,-18,-19,-24,-27,-
45,-46,-47,-48,-49,-50,-65,-104 
CTX-M group 25: main members are CTX-M-25,-26,-39,-41, 
(CANTON & COQUE, 2006; PFEIFER et al., 2010; CANTON et al., 2012) 
 
Phylogenetic analyses suggest that CTX-Ms did not originate by point 
mutations from plasmid mediated enzymes as TEM and SHV, but through 
mobilization of chromosomal β-lactamase genes from different environmental 
Kluyvera (K.) species onto plasmids (CANTON et al., 2012). K. ascorbata is 
thought to be the progenitor of CTX-M-1 and -2 group enzymes (HUMENIUK 
et al., 2002) and some of the CTX-M-1 group β-lactamase genes seem to 
originate from K. cryocrescens (DECOUSSER et al., 2001). The progenitor of 
CTX-M-8 and -9 enzymes is thought to be from K. georgiana (POIREL et al., 
2002).  
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ESBL resistance genes and resistance determinants against aminoglycosides, 
tetracycline, fluoroquinolones and sulfonamids are often situated on the same 
plasmid (JACOBY & SUTTON, 1991) and therefore, the use of any of these 
antimicrobials can co-select for all other ones. Plasmids that encode 
antimicrobial resistance genes can also code for genes mediating resistance 
against disinfectants, heavy metal tolerance, virulence and metabolic functions 
and therefore, could be co-selected (BARBOSA & LEVY, 2000) as well. 
 
1.2.1.5. AmpC 
 
The phenotypic resistance patterns are similar to ESBLs, as AmpC β-
lactamases are able to hydrolyze penicillins and cephalosporins, including 
oxymino-cephalosporins and monobactams. Moreover, they are able to 
hydrolyze cephamycins. AmpC β-lactamases however, are not inhibited by 
clavulanate, sulbactam and tazobactam (LI et al., 2007). Resistance can be 
mediated by hyperproduction of chromosomal AmpC β-lactamases which is 
caused by promoter mutations increasing the transcription rate (CAROFF et 
al., 2000), or can be due to plasmidic AmpC enzymes. Plasmidic enzymes 
belong to Ambler Class C and fall into six phylogenetic groups, CMY-2 being 
the most predominant one (EFSA, 2011). 
 
 
1.3. Epidemiology 
 
1.3.1. Human hosts 
 
To assess the spread of ESBLs in humans, animals and food, data about the 
prevalence in different hosts is needed. However to date, there is still a lack of 
studies on a country-wide scale as most reports describe only circumscribed 
areas. Furthermore harmonized methodologies used in the studies would 
make it easier to compare prevalence rates from different countries as the use 
of selective media for the detection of ESBL increases detection rate and 
therefore, prevalence.  
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Another important fact is that especially in humans, prevalence rates of ESBL 
E. coli are mostly reported from clinical isolates from hospitals or the 
community. As E. coli are not only pathogenic bacteria but also commensal it 
would be necessary to test healthy people to determine the real prevalence of 
ESBL E. coli in humans. However, these studies are scarce (PFEIFER et al., 
2013). 
 
A significant increase in ESBL-producing bacteria was detected in the EU for 
the period 2008-2011 with great variations in the occurrence and  distribution 
among different countries: E. coli isolates resistant to 3rd generation 
cephalosporins were reported from 29 European countries with prevalences 
ranging from 3% in Sweden up to 36.2% in Cyprus (Figure 1) (ECDC, 2012). 
Among these resistant isolates between 85% and 100% were reported to be 
ESBL positive. In Germany occurrence of resistance to 3rd generation 
cephalosporins in E. coli  increased from 1.7% in 2005 to 8% in 2011 (ECDC, 
2012).  
In the United States increasing numbers of E. coli resistant to 3rd generation 
cephalosporins were reported by the MYSTIC program (RHOMBERG & 
JONES, 2009) with 0.5% in 1999 to 5.1% in 2008. Another publication with 
data from the same surveillance program (GOOSSENS & GRABEIN, 2005) 
determined the prevalence of ESBL phenotypes in E. coli in Europe and the 
U.S for the year 2004: In Europe 10.8% of all E. coli isolates were described 
as ESBL-producing in contrast to 1.4% in the U.S.  
In the Asia-Pacific region the total prevalence of phenotypic ESBL E. coli was 
described to be 7.5% in the SMART study in 2010 (HSUEH, 2012). This study 
further reported occurrence rates of E. coli resistant to 3rd generation 
cephalosporins from 21.3% in China up to 61.5% in Singapore for the same 
year. In Latin America ESBL phenotype rates in E. coli ranged from 12.8% in 
Brazil up to 48.8% in Mexico for the years 2008-2010 (GALES et al., 2012).  
 
In most European countries ESBL-producing E. coli are recognized to be 
endemic with a dominance of CTX-M enzymes. In other countries, such as the 
USA, CTX-M-producing E. coli have only been sporadically reported (Figure 2). 
II. Literature Overview 
 
11 
 
In the U.S. detection of ESBLs is less frequent, however, CMY-like β-
lactamases are reported more often there than in Europe (DOI et al., 2010).  
 
 
 
FIGURE 1. Percentage (%) of invasive E. coli isolates with resistance to third-
generation cephalosporins by country, 2011 (ECDC, 2012). 
 
 
ESBLs are distributed worldwide inequally with some CTX-M enzymes being 
well represented in circumscribed geographic regions: In Northern European 
countries a dominance of CTX-M and SHV enzymes is reported, with CTX-M-
1 being the predominant group followed by CTX-M-9-like enzymes. High 
prevalence of CTX-M-9 group enzymes were described in the countries 
surrounding the Mediterranean Sea and in the United Kingdom (UK) as well. 
Furthermore, in Southern European countries and the UK CTX-M-1, CTX-M-
14, and to a lesser extent SHV and TEM enzymes are represented. CTX-M-3 
has been mainly described in Eastern European countries, where SHV and 
II. Literature Overview 
 
12 
 
TEM were sporadically found, too. In South America and Japan CTX-M-2 
enzymes are the predominant ESBLs and in Belarus and Russia CTX-M-5. 
CTX-M-15 is spread nearly worldwide among humans (COQUE et al., 2008). 
 
 
FIGURE 2. Geographic distribution of ESBL resistance genes in humans 
[altered from CANTON & COQUE (2006)]. 
 
1.3.2. Animal hosts 
 
ESBL E. coli has been detected in a broad range of different animals including 
food-producing animals (BRINAS et al., 2003; MEUNIER et al., 2006; 
HORTON et al., 2011), pets (COSTA et al., 2004; CARATTOLI et al., 2005) 
and wild animals (POETA et al., 2009; BONNEDAHL et al., 2010; 
RADHOUANI et al., 2013). However, as described above, different methods 
can make it difficult to compare prevalence rates from various studies. 
The occurrence of ESBL E. coli in poultry ranged from 10.7% in France, to 
54.5% of broilers in Poland, 63.4% of chickens at the slaughterhouse in 
Switzerland and up to 79.9% of poultry tested in Spain (BLANC et al., 2006). 
In a Dutch study (DIERIKX et al., 2013) 85% of chicken farms had a within-
flock prevalence of 80% and first results of a Germ
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conducted within the RESET joint research project reported 74% of tested 
fecal samples from broilers harboring phenotypic ESBL E. coli (HERING, 
2012).  
In pigs prevalence of ESBL E. coli ranged from 12% in 2010 to 4.5% in 2011 
in Denmark, 15.3% in Switzerland, 33.3% in Poland and up to 100% in a 
Spanish study (BLANC et al., 2006). The German study described above 
(HERING, 2012) reported 68% of tested pigs shedding phenotypic ESBL E. 
coli.  
Prevalence of ESBL E. coli in cattle was reported to be 13.7% in Switzerland 
(GESER et al., 2012), 4.1% in France (MADEC et al., 2008), 44.3% in Great 
Britain (HORTON et al., 2011) and 10.2% in Denmark (DANMAP, 2012). In a 
study carried out in southern Bavaria ESBL E. coli could be detected in 32.8% 
of samples originating from cattle and their environment (SCHMID et al., 2013).  
 
Similar as in humans, ESBLs are spread differently among food animals and 
food in European countries: CTX-M-1 is predominantly reported in most 
European countries. CTX-M-14 and CTX-M-32 enzymes are more commonly 
found in countries surrounding the Mediterranean Sea and Southern European 
countries, whereas CTX-M-14 was found in food animals in the UK and 
Belgium, too. In Central and Northern European countries, including the UK 
and Ireland, CTX-M-2 was detected as well. However, in contrast to human 
ESBLs CTX-M-15 was only sporadically reported in animals. Furthermore, 
SHV- and TEM-producing isolates were detected in food-producing animals 
and food, especially SHV-12, SHV-2 and TEM-52 (EFSA, 2011). 
 
1.3.3. Food from animal origin 
 
ESBL E. coli were not only reported in food-producing animals but also in their 
products: In Germany cefotaxime resistant E. coli were detected in laying hens, 
broilers, turkeys, pork, veal, and bulk tank milk. However, highest prevalence 
rates were found in  broilers in 2010 with 13.5% of all E. coli isolates being 
resistant against cefotaxime followed by veal with 10.3% (BFR, 2011). 
Detection rates for other food products originating from animals ranged from 0-
3.2% (Table 2). In Denmark ESBL E. coli were commonly isolated from 44% of 
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broiler meat in 2011 and very rarely in pork and beef (0-0.9%) (DANMAP, 
2012). In contrast to other European countries Sweden has not detected any 
ESBL E. coli in pork, however, 44% of broiler meat samples were positive. 
Reports from the Netherlands show that 84-100% of poultry meat was positive 
for ESBL. 
 
TABLE 2. Percentage of E. coli isolates resistant against cefotaxime obtained 
from various animals and matrices in 2010 (BFR, 2011). 
 
 
1.4. Transmission 
 
ESBLs have been detected in humans, in a variety of animal species and they 
could also be found in food products. Studies show that commensal  E. coli 
can be a reservoir for similar resistance genes in human and animal hosts: 
LEVERSTEIN-VAN HALL et al. (2011) screened samples from poultry, retail 
chicken meat and humans for the presence of ESBL E. coli and the isolates 
were further analyzed to detect a potential genetic relationship between 
human and animal isolates. This study reported that ESBL genes, located on 
plasmids, were genetically indistinguishable from human and poultry E. coli 
isolates. Most of these genes were CTX-M-1 and TEM-52 producers with 
indistinguishable plasmids and isolate genotypes. These findings suggest that 
a transmission of ESBLs via the food chain may potentially occur. 
 
 
 
 
 
 
 
Laying 
hens 
Broilers Turkeys 
Turkey 
meat 
Veal 
calves 
Bulk tank 
milk 
       
E. coli 
isolates 
27/1001 
(2.7%) 
27/200 
(13.5%) 
0/127 
(0%) 
8/356 
(2.2%) 
28/272 
(10.3%) 
3/95 
(3.2%) 
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1.5. Public health consequences  
 
For many years the public health consequences of antimicrobial resistant 
bacteria transmitted from food animals to humans have been discussed. 
Consequences include reduced efficacy of early empirical treatment, 
limitations in the choices for treatment after microbiological testing, leading to 
more frequent treatment failures. Furthermore, this can result in increased 
severity of infection, increased duration of illness, and increased risk of 
hospitalization or mortality (ANGULO et al., 2004; MOLBAK, 2004).  
 
Humans themselves can be a source of ESBL producing bacteria especially in 
hospitals: ESBLs are usually more prevalent in wards with hospitalized 
patients at high risk, i.e. in intensive care units, surgical wards, pediatrics and 
neonatology wards (GNIADKOWSKI, 2001). Resistant bacteria can be 
transmitted from patient to patient and it may also be imported from a new 
patient entering the hospital, leading to nosocomial infections. In 2011 a 
nosocomial outbreak of ESBL producing Klebsiella pneumoniae took place in 
a neonatology ward of a hospital in Bremen, Germany. In 25 children K. 
pneumoniae could be detected, nine children developed a sepsis and four 
eventually died (STAUCH, 2011). 
 
Another consequence for public health is that commensal E. coli can be a 
reservoir for ESBL resistance genes and can potentially pass these genes to 
pathogenic bacteria as e.g. Salmonella spp. (WINOKUR et al., 2001). The only 
approved treatment of Salmonella infections in children is ceftriaxone which is 
a third generation cephalosporin, similar to ceftiofur, used as treatment of 
companion and food animals. Ceftriaxone is further used in the treatment of 
fluoroquinolone-resistant salmonellosis in adults (DUNNE et al., 2000). 
Scientists are discussing a potential occurrence of cross resistance among 
these two antimicrobials leading to treatment failures of Salmonella infections 
in humans.  
 
Furthermore, ESBL resistance genes are often located on the same plasmids 
as resistance determinants against aminoglycosides, tetracycline and 
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sulfonamids (JACOBY & SUTTON, 1991). These plasmids can also carry 
genes mediating resistance against disinfectants, heavy metal tolerance, 
virulence and metabolic functions (BARBOSA & LEVY, 2000). Due to the 
coexistence of multiple resistance determinants on a single plasmid the use of 
one antimicrobial can result in selecting resistance to all other antimicrobials. 
 
 
II. Clostridium difficile 
 
2.1. Clostridium difficile - general information 
 
Clostridium difficile (C. difficile) are strictly anaerobic, gram-positive bacilli 
measuring 2.5-5.9 x 0.3-1.5 µm. The shape varies from very short to large 
rods which can produce subterminal endospores. The organisms are motile 
due to peritrichous flagella and they are both catalase- and oxidase-negative 
(HAFIZ & OAKLEY, 1976). 
 
The virulence of C. difficile is mainly related to the production of two protein 
exotoxins, toxin A and toxin B, encoded by the tcdA and tcdB genes. Toxin A 
is an inflammatory enterotoxin that possesses weak cytotoxic activity, in 
contrast to toxin B, which is a very potent cytotoxin (KYNE et al., 2001). Both 
toxins cause increased vascular permeability and hemorrhage, however, toxin 
A can further cause fluid accumulation shown in various animal models 
(LYERLY et al., 1985). Some strains have an additional binary toxin (CDT) 
(POPOFF et al., 1988), encoded by cdtA and cdtB genes, which has cytotoxic 
and enterotoxic activities (CARMAN et al., 2011). 
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2.2  Epidemiology 
 
2.2.1.  C. difficile infection in humans 
 
C. difficile infection (CDI) in humans can range from asymptomatic carriage to 
uncomplicated diarrhea up to severe and life-threatening pseudomembranous 
colitis often with systemic symptoms, i.e. fever, nausea, anorexia, malaise and 
dehydration (KELLY et al., 1994). CDIs are usually nosocomial infections and 
most cases have been documented in the hospital environment.  
 
The main risk factors for acquiring a CDI are use of antimicrobials, 
hospitalization, severity of underlying disease and an age > 65 years. Due to 
antibiotic therapy the normal colonic microbiota is disturbed, ingested spores 
can germinate and C. difficile can colonize the colon, producing toxins. This 
can result in an asymptomatic carriage and contamination of the hospital 
environment or in diarrhea and colitis (KYNE et al., 2001). However, surveys 
in postnatal wards show that neonates are often transiently colonized by 
toxigenic C. difficile without developing disease (LARSON et al., 1982). A 
study performed by EGLOW et al. (1992) suggests that this resistance in 
neonates could be due to immature toxin receptors.  
 
Recently, an increase of incidence and severity has been reported in hospitals 
in the U.S. where the diagnosis of CDI has been doubled from 31 per 100,000 
people in 1996 to 61 per 100.000 in 2003 (MCDONALD et al., 2006). This 
increase seems to be related to the emergence of a new, hypervirulent strain, 
namely PCR ribotype 027. Ribotype 027 is characterized as toxinotype III, 
North American pulsed field gel electrophoresis type 1 (NAP1) and carries 
genes for toxin A and B and the binary toxin (LOO et al., 2005; MCDONALD et 
al., 2005). The increase of virulence appears to be due to the hyperproduction 
of toxins (WARNY et al., 2005). This strain has not only emerged in Northern 
America but also in Japan and Europe where CDI has been associated with 
increased severity, high relapse rate and significant mortality (Figure 3).  
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FIGURE 3. Distribution of C. difficile ribotype 027 in Europe as of June 2008 
(KUIJPER et al., 2008). 
 
Furthermore, another new strain, namely PCR ribotype 078, has been 
described to be one of the most prevalent strains in Europe (BAUER et al., 
2011). Ribotype 078 is characterized as toxinotype V and contains genes for 
toxins A and B as well as the binary toxin. In contrast to type 027, 078 affects 
a younger population with similar severity and is more frequently community 
associated (GOORHUIS et al., 2008). The main PCR ribotypes found in 
human CDI cases in Germany are 001, followed by 078 and 027 as shown in 
Figure 4. 
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Recently published data from the U.S. reported an increase of CDI in non-
hospitalized patients (KHANNA et al., 2012). This study showed that 41% of 
385 CDI cases were community-associated affecting people that have 
previously been thought to be at low risk, as young adults and children without 
any exposure to antimicrobials or hospitals. 
 
 2.2.2.   C. difficile infection in animals 
 
C. difficile has been detected in fecal samples from a variety of healthy and 
sick animals, however to date, their definite significance as a primary 
pathogen has not yet been clearly identified for all animal species. 
C. difficile was documented as a major cause of enteritis in neonatal pigs 
which start scouring shortly after birth, sometimes with dyspnea, mild 
abdominal distension and scrotal edema and commonly with yellow, pasty 
diarrhea (WATERS et al., 1998; SONGER et al., 2000).  
 
In adult horses C. difficile was associated with antibiotic-associated diarrhea 
but it could also be isolated from untreated diarrheic horses (BAVERUD et al., 
2003). Furthermore, the study showed, that C. difficile could also be isolated 
from one in three normal healthy foals < 14 days of age. WEESE et al. (2001) 
reported that C. difficile was isolated from 12.7% of horses and 35.5% of foals 
with colitis. 
 
Poultry is the food animal species which has been less investigated 
concerning the occurrence of C. difficile in general and its role as a primary 
pathogen. There are no studies about clinical symptoms in poultry related to C. 
difficile and only a few which detected it in healthy poultry (SIMANGO, 2006; 
INDRA et al., 2009; KOENE et al., 2012). 
In cattle C. difficile was suggested to be associated with calf diarrhea as toxins 
could be detected more often in diarrheic than in non-diarrheic calves 
(RODRIGUEZ-PALACIOS et al., 2006). The same authors conducted another 
study where calves were orally inoculated with C. difficile (RODRIGUEZ-
PALACIOS et al., 2007): The organism could be cultured from seven of eight 
inoculated calves and from none of the control calves, but no detection of 
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toxins or induction of enteric disease was possible. Furthermore, five of six 
control calves developed diarrhea and only two of the inoculated ones, which 
questions the role of C. difficile as a primary pathogen in calves.  
 
C. difficile has been reported from healthy and sick dogs and cats in Germany 
(WEBER et al., 1989) however, these authors did not suggest that C. difficile 
is a significant pathogen for enteritis in pets. Another study showed that 
shedding of C. difficile in dogs is not correlated with clinical diarrheal signs 
even among toxigenic strains (STRUBLE et al., 1994; WEESE et al., 2010a). 
 
 
2.3. Public health consequences 
 
Public health consequences have been widely discussed for C. difficile, 
however, no transmission from animals or food to humans has yet been 
documented. Various authors suggest a possible spread of C. difficile from 
animals to humans, not only limited to food animals (ARROYO et al., 2005) 
but also from companion animals (BAVERUD et al., 2003; WEESE et al., 
2010a). The organism could be found in various sick animals as well as in 
healthy ones, shedding C. difficile into the environment and therefore, being a 
potential reservoir. 
 
Furthermore, C. difficile was not only isolated from food animals but also from 
their products: Various studies isolated it from ground beef and veal with 
prevalence rates ranging from 0% in Austria and The Netherlands (INDRA et 
al., 2009; DE BOER et al., 2011) up to 50% in the U.S. (SONGER et al., 2009). 
The same study further revealed that C. difficile was found in pork and turkey 
products as well as in ready-to-eat products. Moreover, raw vegetables, and 
samples from the environment, i.e. soil, river, sea and tab water, were found to 
harbor C. difficile (AL SAIF & BRAZIER, 1996).  
These findings suggest that animals, food and the environment can be a 
potential reservoir for C. difficile, however, to assess a possible spread genetic 
relatedness has to be evaluated: In calves 94% of all strains and in pigs 83% 
belonged to PCR ribotype 078 (KEEL et al., 2007) and strains obtained from 
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meat samples (SONGER et al., 2009; WEESE et al., 2010b) shared the same 
ribotype which is one of the most prevalent strains in Europe (Figure 4).  
 
KOENE et al. (2012) reported a genotypic relation of some porcine and human 
ribotype 078 strains by multiple locus variable-number tandem-repeat analysis 
(MLVA). However, they also concluded that most strains are predominantly 
animal host specific, whereas some strains share ribotypes among different 
animal species, as well (KOENE et al., 2012). Another Dutch study (DEBAST 
et al., 2009) identified a clonal complex, containing porcine and human 
ribotype 078 strains which showed a similar antimicrobial susceptibility profile 
and concluded that these strains were indistinguishable. 
Although existing studies report of genetically closely related strains among 
animals and humans the actual transmission of C. difficile to humans has 
never been proved, therefore it is still unclear if C. difficile is a potential 
foodborne agent. 
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FIGURE 4. Frequency of isolation of toxigenic C. difficile PCR ribotypes from 
humans, young cattle, and various foods (RODRIGUEZ-PALACIOS et al., 
2013). 
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3. Clostridium botulinum 
 
3.1.  Clostridium botulinum – general information 
 
Clostridium (C.) botulinum is a large, gram-positive, anaerobic, rod-shaped 
bacterium which produces subterminal endospores. The endospores are 
distributed in soils and aquatic environments worldwide and germination of 
them occur in anaerobic locations as in decaying organic matter or in 
contaminated cans of meat or vegetables (QUINN et al., 2001).  
 
C. botulinum produces eight neurotoxins (BoNT), namely types A, B, C1, C2, D, 
E, F, and G. They are among the most toxic substances known (mouse 
LD50<0.1ng/kg). Types A, B, E, and very rarely F cause human botulism 
outbreaks, whereas types C and D are linked with most botulism outbreaks in 
animals. There is no evidence that type G (now C. argentinense) can cause 
disease (DODDS & AUSTIN, 2001). BoNTs A, B, E, and F are encoded by 
genes on the bacterial chromosome, in contrast to C and D where genes are 
encoded by bacteriophages and genes for BoNT G are located on a plasmid 
(DODDS & AUSTIN, 2001). Furthermore, C. botulinum is divided into four 
groups based on physiological differences as shown in Table 3. 
 
TABLE 3. Grouping of strains of C. botulinum altered from DODDS & AUSTIN 
(2001). 
Characteristics I II III IV 
Neurotoxin 
type(s) 
A, B, F B, E, F C, D 
G  
(now  
C. argentinense) 
Proteolysis + - - - 
Outbreaks 
Humans, 
animals 
Humans, 
animals 
Animals - 
Toxin gene Chromosome Chromosome Bacteriophage Plasmid 
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3.2.  Epidemiology 
 
3.2.1. C. botulinum infection in humans 
 
Human botulism can be divided into five categories (DODDS & AUSTIN, 2001; 
SOBEL et al., 2005): 
 
a) Foodborne botulism 
Foodborne botulism is an intoxication which is caused by  
consumption of food contaminated with preformed BoNT. The toxins 
are absorbed from the gastrointestinal tract and reach peripheral 
motor nerve terminals via the blood stream. There, they block 
neurotransmission by inhibiting acetylcholine release which results in 
flaccid paralysis (DODDS & AUSTIN, 2001). 
 
b) Infant botulism 
This type of botulism is caused by ingestion of spores which can 
germinate and colonize the intestinal tract of infants less than one 
year of age, as the normal intestinal flora has not yet been fully 
established. Subsequently, neurotoxins are produced which are then 
absorbed and result in flaccid paralysis. This is the most common 
form of botulism in the United States (CDC, 2010). 
 
c) Infectious botulism 
Infectious botulism or adult intestinal toxemia botulism is due  
to ingestion of spores that are able to germinate and produce toxins 
which are subsequently absorbed and result in flaccid paralysis. This 
is possible if the normal intestinal flora is altered because of surgery, 
inflammation or use of antimicrobials (SOBEL, 2005). 
 
d) Wound botulism 
Wound botulism is caused by contamination of a wound with C. 
botulinum spores which subsequently germinate and produce BoNTs 
in the anaerobic milieu of the wound. Since the 1990s this form of 
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botulism has dramatically increased, almost exclusively among 
injection drug users, especially in the western U.S. (WERNER et al., 
2000). 
 
e) Unclassified cases 
This category includes cases of unknown origin (DODDS & AUSTIN, 
2001). 
 
3.2.2. C. botulinum intoxication in animals 
 
Naturally occurring outbreaks of C. botulinum have been described in several 
animal species, including domestic and wildlife animals (TRAMPEL et al., 
2005; WOO et al., 2010; PAYNE et al., 2011). In general neurotoxin types C 
and D are associated with clinical outbreaks in animals; however, outbreaks in 
different species can be related to other types, as well.  
In poultry BoNT type C is the predominantly found type (SMART & ROBERTS, 
1977; TRAMPEL et al., 2005) in contrast to horses where 85% of all outbreaks 
were due to type B and to a far lesser extent to type A and C (WHITLOCK & 
MCADAMS, 2006). A toxicoinfectious form of botulism exists in foals, named 
the shaker foal syndrome, which is characterized by progressive muscular 
weakness. It results from ingested spores, germinating and producing toxin in 
the intestinal tract (WILKINS & PALMER, 2003). Furthermore, equine grass 
sickness has been considered to be a form of botulism resulting from 
overgrowth of C. botulinum type C in the intestinal tract (MCCARTHY et al., 
2004). 
 
Large outbreaks of botulism in cattle have been reported from the UK, 
Switzerland and Israel (LINDSTROM et al., 2010) which were mainly linked to 
BoNT types C and D, although types A and B were reported, too 
(NOTERMANS et al., 1981; SCHOCKEN-ITURRINO et al., 1990). The main 
risk factors for cattle ingesting BoNT is silage which supports growth of C. 
botulinum due to its anaerobic atmosphere, especially when accidentally 
contaminated with a dead animal (STEINMAN et al., 2006; MYLLYKOSKI et 
al., 2009). Furthermore, poultry litter is linked to botulism outbreaks in cattle 
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(PAYNE et al., 2011) as well as brewers grain (NOTERMANS et al., 1981) and 
bakery waste (HEIDER et al., 2001).  
Recent reports suggest a new form of botulism in cattle, namely intestinal 
botulism or “visceral botulism”. However, its etiology and pathogenesis is not 
clear. Scarce studies discuss ingestion of spores that shall colonize the lower 
intestinal tract and may produce BoNT which is subsequently absorbed by the 
mucous membrane where motor nerve synapses and autonomic 
parasympathetic synapses are affected (BOEHNEL et al., 2001; KRUEGER et 
al., 2012). However to date, there is no scientific evidence supporting this 
hypothesis (BFR, 2010). 
 
3.2.3. C. botulinum in food 
 
C. botulinum has been detected in several foods, including food products from 
non-animal and animal origin, which all caused foodborne botulism outbreaks: 
Food products from non-animal origin include preserved olives in Finland 
(JALAVA et al., 2011), garlic preserved in oil in Denmark (LOHSE et al., 2003), 
home preserved asparagus in Italy (ZANON et al., 2006) and several home-
canned vegetables in the U.S. (DATE et al., 2011). Food products from animal 
origin, which caused foodborne botulism, include meat from different animal 
species and fish, particularly raw, smoked/salted or vacuum packed products 
of it (RKI, 2003, 2004; KING et al., 2009; RKI, 2010).  
 
Moreover, honey can contain spores of C. botulinum and has been described 
to be one of the risk factors for infants acquiring infant botulism (SPIKA et al., 
1989). Therefore, feeding honey to infants less than one year of age is not 
recommended (CDC, 1998).  
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3.3.  Public health consequences 
 
In 2010 seven C. botulinum outbreaks were reported by the EFSA in Europe 
(EFSA & ECDC, 2012) indicating that this is a rare, but severe disease. A total 
of 21 cases and one death were associated with these outbreaks and they 
were all foodborne. The most common food source was meat (uncategorized), 
pork meat followed by fish and fish products, vegetables, juice and juice 
products. 
Most often outbreaks from commercially prepared food occur due to a failure 
in recipes, process, packaging or lack of temperature control. However, a high 
percentage of botulism outbreaks were caused by homemade foods, 
particularly home-canned food (EFSA, 2005), which were either improper 
stored, handled or heated.  
 
Furthermore, C. botulinum has been detected in healthy animals 
(DAHLENBORG et al., 2001, 2003) suggesting a possible risk of 
contaminating their products, namely meat via carcass contamination during 
the slaughter process, and milk. However, studies show that standard 
pasteurization conditions inactivate > 99% of BoNTs in milk (WEINGART et al., 
2010) and heating food at 80°C inactivates BoNTs as  well (CDC, 1998). 
Therefore, proper handling and heating of food is essential to reduce the risk 
of ingesting BoNT via food. 
 
 
4. Yersinia enterocolitica 
 
4.1.  Yersinia enterocolitica – general information 
 
Yersinia (Y.) enterocolitica is a gram-negative, rod-shaped, motile, facultative 
anaerobe which is oxidase-negative, catalase-positive and ferments glucose. 
The genus Yersinia is a member of the family Enterobacteriaceae. Y. 
enterocolitica is divided into subgroups by bio- and serotyping according to the 
biochemical activity and lipopolysaccharide (LPS) O antigens. Most human 
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and animal infections are due to biotype 1B, 2, 3, 4, and 5, whereas 1A is 
often referred to as an environmental biovar. Common serovars obtained from 
humans are O:3, 9, 5, and 27. In animals, primarily cattle, serotype O:9 is of 
particular importance as LPS from Y. enterocolitica  cross-reacts with LPS 
from Brucella spp. and may induce false-positive reactions in brucella 
agglutination tests (WEYNANTS et al., 1996). 
 
Virulence factors of Y. enterocolitica consist of adhesins which are encoded on 
the chromosome, as invasin and ail which mediates bacterial attachment and 
invasion and also protects Y. enterocolitica from nonspecific destruction by the 
complement system. The ail gene is only found in virulent serovars. 
Furthermore, Y. enterocolitica secrete heat-stable enterotoxins (Yst) which are 
also encoded on the chromosome. Virulent Y. enterocolitica carry a plasmid 
(pYV) which encodes proteins called YopB (Yersinia outer proteins), -D, -E, -H, 
-M, -N, -O, -P, -Q, and -R and YadA (Yersinia adhesin), YlpA, LcrV. These 
proteins are virulence factors with a number of them acting on host cells to 
subvert immune defense (DOYLE et al., 2001). 
 
 
4.2.  Epidemiology 
 
4.2.1. Y. enterocolitica infection in humans 
 
Y. enterocolitica is a worldwide foodborne pathogen causing yersiniosis which 
is the third most commonly reported zoonosis in Europe (EFSA & ECDC, 
2012). In 2010 6,776 confirmed cases were reported in the EU with 3,346 
confirmed cases reported from Germany (EFSA & ECDC, 2012). Sporadic 
outbreaks of yersiniosis occur most often in children less than five years of 
age and the highest incidence is among one year olds with 49 per 100,000 
population in 2010 in Germany (RKI, 2012). Most symptomatic infections 
result in self-limiting diarrhea, however, suppurative and autoimmune 
complications can occur, as well.  
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In Europe serovar O:3 is the most frequently isolated one from humans, 
followed by serovar O:9  and the most frequent biovar worldwide is biovar 4 
(Table 4).  
 
TABLE 4. Geographic distribution of serovars and biovars of Y. enterocolitica 
(BOTTONE, 1997). 
Geographic distribution Serovar Biovar 
United States O:8 1B 
 O:3 4 
Canada O:3 4 
Europe O:3 4 
 O:9 2 
Japan O:3 4 
South Africa O:3 4 
 
 
4.2.2. Y. enterocolitica infection in animals 
 
Natural Y. enterocolitica infections in animals have rarely been reported: In 
goats and sheep it causes enteritis and microabscesses in the intestine (SLEE 
& BUTTON, 1990) and sporadic ovine abortion (CORBEL et al., 1990). It was 
furthermore detected in chinchillas and other rodents causing enteritis 
(WUTHE & ALEKSIC, 1992). Experimental infection of rodents with Y. 
enterocolitica resulted in purulent meningoencephalitis, catarrhal pneumonia 
and arthritis (DE LOS TOYOS et al., 1990; VESSELINOVA et al., 2001). In 
experimentally infected pigs histological findings were meningoencephalitis as 
well as catarrhal enteritis and necrotic tonsillitis (NAJDENSKI et al., 1998).  
 
Moreover, Y. enterocolitica could be detected in feces of clinically healthy 
animals, as in pigs, cattle, sheep (MCNALLY et al., 2004) and even 
companion animals and rodents (BUCHER et al., 2008). Y. enterocolitica 
though, is more frequently detected in healthy pigs and pigs at the 
slaughterhouse than in other animal species (EFSA & ECDC, 2012). 
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4.2.3.  Y. enterocolitica in food 
 
Pathogenic Y. enterocolitica strains were frequently found in pork meat, 
especially edible offal and tongue (FREDRIKSSON-AHOMAA et al., 1999; 
BUCHER et al., 2008; MESSELHÄUSSER et al., 2011). Moreover, other 
sources of foodborne transmission were described in the U.S.: A case of 
human yersiniosis was reported after drinking pasteurized milk (CDC, 2011) 
and another American study reported Y. enterocolitica in bulk tank milk 
(JAYARAO et al., 2006).  
Furthermore, Y. enterocolitica was detected in beef and meat originating from 
chicken and turkey (MAYRHOFER et al., 2004) as well as in ready-to-eat 
salad (MACDONALD et al., 2012).  
 
 
4.3. Public health consequences 
 
Animals, particularly pigs and their products, are considered to be the main 
reservoir for human pathogenic Y. enterocolitica as they mainly harbor biotype 
4 (O:3). Human pathogenic biotype 4 (O:3) and 2 (O:9) have been detected in 
other animals as well, namely cattle, sheep, dogs and cats however, with a far 
lesser extent (EFSA & ECDC, 2012). Nevertheless, they still can act as a 
reservoir. The main risk factor for acquiring Y. enterocolitica appears to be 
eating raw or undercooked food, especially pork which is a preventable cause 
of foodborne disease due to proper preparing and handling of food (RKI, 2012). 
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IV.  DISCUSSION 
 
1. ESBL E. coli 
 
The study about the prevalence of ESBL E. coli on Bavarian dairy and beef 
cattle farms was conducted within the RESET joint research project 
(www.reset-verbund.de) including research projects in humans, different 
animal species, the environment and food across Germany. This 
interdisciplinary joint research project has been funded by the Federal Ministry 
of Education and Research (Bundesministerium für Bildung und Forschung). 
The aim of this research project is to assess the effect of ESBL E. coli, their 
origin, way of transmission and the risk for humans being exposed to them. On 
the basis of this assessment possible recommendations can be made 
concerning the control of resistant bacteria on a rational basis. These 
discussions are necessary to determine potential risks of the spread of ESBL 
E. coli and to further implement actions if needed, particularly on a legal level, 
such as improving control of antimicrobial usage, restricted use of single 
agents, etc.   
 
To prevent the occurrence and spread of resistant bacteria guidelines on 
prudent use of antimicrobials exist in veterinary medicine in contrast to human 
medicine. The “guidelines for the careful handling of antibacterial veterinary 
drugs” (“Leitlinien für den sorgfältigen Umgang mit antibakteriell wirksamen 
Tierarzneimitteln”) (BTK, 2010), have been developed by the working 
committee on veterinary drugs (Arbeitsgruppe Tierarzneimittel der 
Länderarbeitsgemeinschaft Verbraucherschutz, Bundestierärztekammer) and 
provide information on antimicrobial usage specially conceptualized for certain 
animal species. These guidelines give advice on the indication of certain drugs 
as well as dosage and treatment length, trying to minimize consumption in 
veterinary medicine, with the goal of decreasing resistant bacteria. 
 
The study showed that ESBL E. coli are commonly found on Bavarian dairy 
and beef cattle farms: They could be detected on 86.7% of all farms with a 
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prevalence of 32.8% of all samples. A total of 28 of 30 mixed cattle farms and 
11 of 15 beef cattle farms harbored at least one sample that contained ESBL 
E. coli. The prevalence of ESBL E. coli positive fecal samples on mixed cattle 
farms was 39.6% compared to 18.9% on beef cattle farms, which is consistent 
with other European studies: In Switzerland (GESER et al., 2012) 13.7% of 
bovine fecal samples from the slaughterhouse harbored ESBL E. coli, as well 
as 10.2% in Denmark (DANMAP, 2012), 4.1% in France (MADEC et al., 2008) 
and up to 44.3% in the UK (HORTON et al., 2011). The first two studies 
screened bovine fecal samples from the slaughterhouse, whereas the British 
study screened bovine fecal samples from animals on farms and the French 
study screened fecal samples from both origins. Prevalence rates vary in 
European countries, which can be due to different methodologies and sample 
sizes that make comparison of data difficult. However, ESBL E. coli are widely 
spread through-out different countries. 
 
Moreover, on mixed farms fecal samples and boot swabs obtained from the 
calf group were significantly more likely to harbor ESBL E. coli than fecal 
samples and boot swabs from the dairy and beef cattle group. This finding is 
consistent with other studies (WATSON et al., 2012), where CTX-M 
prevalence in calves was up to 98.7% within 21 days of birth. This study 
further showed a decline of prevalence with increasing age of calves: At 117 
days of age only 10% of the calves shed CTX-M E. coli. The authors 
suggested that diet could be one of the reasons why younger calves shed 
more ESBL E. coli than older ones: Pre-weaned calves possess a different gut 
flora than older ones due to a shift in bacteria with less gram negative bacteria. 
Moreover, these authors proposed an age related immune effect which may 
reduce fecal shedding of ESBL E. coli. Other studies (KHACHATRYAN et al., 
2004; BERGE et al., 2006; SINGER et al., 2008) showed as well, that the age 
of a calf is a strong predictor of antimicrobial resistance: Especially pre-
weaned calves seem to be a reservoir for resistant bacteria. However, the 
calves in the study from KHACHATRYAN et al. (2004) and some of the calves 
from the study conducted by BERGE et al. (2006) were fed treated milk 
replacer. BERGE et al. (2006) stated that the use of antimicrobials is a 
dominant selective influence for resistant bacteria which is in consistency with 
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our findings. This may be one of the main reasons why calves are more likely 
to shed ESBL E. coli. They are more prone to develop diseases as diarrhea, 
pneumonia or navel infections than older animals, potentially leading to 
systemic treatment with antimicrobials. The treatment does not have to include 
the use of β-lactam antimicrobials as other classes of antimicrobials can co-
select for ESBL resistance genes in bacteria as well. Resistance determinants 
against cephalosporins, aminoglycosides, fluoroquinolones, tetracycline, 
sulfonamides, as well as disinfectants are often situated on the same plasmid 
and therefore, can be co-selected (JACOBY & SUTTON, 1991). These 
plasmids can also code for genes mediating heavy metal tolerance, resistance 
to ultraviolet light, virulence and metabolic functions (BARBOSA & LEVY, 
2000). Selection for these plasmid-encoded characteristics may also 
contribute to the persistence of plasmid-borne antimicrobial resistance, even in 
the absence of antimicrobial usage. This means, that even without the use of 
beta-lactam antimicrobials or antimicrobials in general, ESBL resistance genes 
can be co-selected and, therefore, can persist in bacteria. 
  
Furthermore, our study indicated that feeding waste milk and, therefore, low 
concentrations of antimicrobials, may pose a potential selective pressure and 
may be an advantage for bacteria with resistance to antimicrobials: Calves 
being fed waste milk harbored more ESBL-producing E. coli-positive fecal 
samples than calves fed otherwise. This difference, however, was not 
significant (p=0.055, median for calves without waste milk, 0.33; median for 
calves with waste milk, 0.83). Similar hypotheses were stated by BERGE et al. 
(2005). 
Moreover, BERGE et al. (2005) detected heifers shedding ESBL E. coli even 
in the absence of antimicrobial therapy. One hypothesis for this finding was 
that individual animal treatment may provide enough selective pressure to 
maintain a resistant gene pool in the farm-level bacteria population and, 
therefore, may spread to not-treated animals.  
In general samples from the beef cattle group of mixed farms and samples 
obtained from beef cattle farms were less likely to harbor ESBL E. coli than 
samples from all other groups. This can be partly due to fewer treatments with 
antimicrobials. Most beef cattle tested in this study were four months and older. 
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Older calves and cattle are less likely to suffer from infectious diseases and, 
therefore, may be treated less often. Furthermore, older calves possess a 
different gut flora because of their diet and a more “aged” immune system 
which may favor the colonization of a more susceptible set of strains (BERGE 
et al., 2005; SINGER et al., 2008). These factors may lead to fewer resistant 
bacteria in this animal group. 
 
In the control group ESBL E. coli could only be detected in boot swabs but not 
in fecal samples. Moreover, much fewer control farms (3 of 10, 30%) were 
positive for ESBL E. coli in contrast to mixed farms and beef cattle farms, 
where at least one sample was positive on 28 out of 30 (93.3%) and 11 out of 
15 farms (73.3%) respectively. This suggests that ESBL E. coli can be found 
more often on farms that use antimicrobials as control farms did not use 
antimicrobials for the last six months, whereas mixed and beef cattle farms did 
use them, except for one beef cattle farm. Antimicrobials have not been used 
in every group on mixed and beef cattle farms, therefore, statistical analysis 
was performed for each group to detect a possible difference in prevalence 
among treated and untreated groups. This analysis, though, only revealed a 
statistical significance for the calf group on mixed farms: Calves being treated 
with antimicrobials shed significantly more often ESBL E. coli than untreated 
calves (p=0.041). For all other groups on mixed and beef cattle farms no 
statistical relation could be determined. This could be due to the small number 
of farms tested and the resulting sample size. With more farms being part of 
the study and the control group the effect of use of antimicrobials on ESBL     
E. coli prevalence rate would probably be more obvious. However, the data 
indicate a potential relation between the use of antimicrobials on farms and the 
detection rate of ESBL E. coli on these farms. 
The study also showed that ESBL E. coli isolates mostly harbored genes 
encoding blaCTX-M, particularly of the CTX-M-1 group. Resistance genes 
belonging to group CTX-M-2 and -9 could be found as well. ESBL resistance 
genes were distributed equally among mixed dairy and beef cattle farms and 
exclusively beef cattle farms. However, AmpC resistance on mixed farms was 
solely due to a mutation of the promoter region in contrast to beef cattle farms 
where plasmid-mediated ampC resistance genes as CMY-2 and FOX could be 
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found, too. In animals and humans the predominantly found resistance genes 
can differ: CTX-M-15 is the predominant bla found in humans, but only 
occasionally found in animals. CTX-M-1, however, is equally detected among 
humans and animals. Moreover, plasmid-mediated ampC resistance genes, 
as found on beef cattle farms, play an important role in the transmission of 
resistance genes. Many resistance genes, as ESBL and ampC, are plasmid-
mediated and can spread more easily via horizontal gene transfer than 
chromosomal ones. This knowledge about predominantly found resistance 
genes in animals, humans and food and their location on either the 
chromosome or plasmids is of main importance when assessing risk factors 
and transmission of resistant bacteria.  
 
The Federal Ministry of Food, Agriculture and Consumer Protection 
(Bundesministerium für Ernährung, Landwirtschaft und Verbraucherschutz, 
BMELV) demands a considerably reduction of antimicrobials in veterinary 
medicine combined with tighter controls and more detailed records, similar to 
approaches made in Denmark and The Netherlands. An amendment of the 
German Medicinal Products Act (AMG) was passed in 2013. The objective of 
this amendment is to reduce use of antimicrobials in livestock and to get 
transparency of the amount of drugs used via a database that records its 
usage. The use of antimicrobials above average can be detected by the 
authorities via this database and interventions and actions can be suggested 
to reduce their consumption. As part of the interventions animal husbandry 
and vaccination protocols need to be evaluated as a decrease of antimicrobial 
consumption also depends on the condition animals are kept under. This will 
reduce the number of infections and, therefore, the need to use antimicrobials 
(FVE, 2011).  
To be able to rationally discuss implementations of legal actions as minimizing 
use of antimicrobials, detailed epidemiologic studies in human and veterinary 
medicine including animal production as well as pet animals are needed. This 
type of studies provides basic knowledge about the occurrence and spread of 
resistant bacteria and can show where improvements are needed. 
Unfortunately, there is still a paucity of studies concerning prevalence rates on 
a regional or country-wide scale in Europe. 
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2. C. difficile, C. botulinum and Y. enterocolitica 
 
C. difficile, C. botulinum and Y. enterocolitica can potentially be transmitted via 
the food chain leading to foodborne zoonosis. The EUROPEAN COUNCIL 
(1992) defined zoonosis as “[…] any disease and/or infection which is likely to 
be naturally transmitted from animals to men” either via direct contact or 
contaminated food. To prevent zoonoses, it is important to identify which 
animals and food are the main sources of infections. Therefore, data collection 
and analysis is essential and supports prevention and reduction of 
transmission of pathogens via animals or food.  
 
There are only limited data available concerning prevalence rates of C. difficile, 
C. botulinum and Y. enterocolitica in healthy cattle, especially concerning the 
last two pathogens. Moreover, data about prevalence rates of C. botulinum 
and Y. enterocolitica are possibly outdated as most studies were conducted 
more than a decade ago. Therefore, we assessed prevalence rates of C. 
difficile, C. botulinum and Y. enterocolitica in healthy dairy and beef cattle in 
Bavaria. This study revealed that C. difficile and Y. enterocolitica could rarely 
be found in healthy cattle with prevalence rates of 5.7% and 1.6% respectively. 
In contrast to previous studies C. botulinum could not be detected in fecal 
samples, but very rarely in dust samples (0.8%) from the cattle environment. 
Other studies detected C. botulinum in fecal samples, with prevalence rates 
ranging from 4% (KLARMANN, 1989) up to 73% in cattle (DAHLENBORG et 
al., 2003). This variation may be due to different methodologies, but moreover, 
to regional differences: In countries surrounded by water, particularly the 
Northern countries in the EU, C. botulinum spores can commonly be found in 
the water and soil (SMITH & YOUNG, 1980; HIELM S et al., 1998) 
representing a potential reservoir for animals. One of these studies was 
conducted by Klarmann et al. in Germany in 1989 and showed different results. 
These variations of findings in the same country could be due to changes of 
prevalence in the course of time, but could also be due to sample sizes: 
Klarmann et al. screened 25 bovine fecal samples for the occurrence of C. 
botulinum yielding one positive sample (4%). 
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C. difficile could not be detected in beef cattle prior to slaughter as well as Y. 
enterocolitica. Moreover, both pathogens were only rarely found in lactating 
dairy cows with prevalences of 2.9% each. Contamination of meat could occur 
during the slaughter process by carcass coming into contact with intestinal 
contents and contamination of milk could occur during the milking process by 
improper hygiene management. As fecal samples obtained from beef cattle 
prior to slaughter were negative for C. difficile and Y. enterocolitica and these 
pathogens could only rarely be found in lactating dairy cows this suggests that 
these pathogens as well as C. botulinum, which could not be detected in 
bovine fecal samples at all, are unlikely transmitted via milk and meat.  
 
3. Conclusion  
 
The present study shows that ESBL-producing E. coli can commonly be 
found on Bavarian dairy and beef cattle farms, though, at different 
prevalence rates depending on the farm type. On mixed farms calves were 
more likely to shed ESBL E. coli followed by cows and beef cattle. It indicates 
that resistant bacteria are present in groups where antimicrobials have been 
used and suggests that calves may be a reservoir for these bacteria. The 
results were consistent with other European studies revealing that ESBL E. 
coli are widely spread all over Europe as well as the rest of the world.  
The data further suggest that dairy and beef cattle seem to be a minor source 
for transmitting C. difficile, C. botulinum and Y. enterocolitica to humans via 
the food chain. However, this data does not necessarily have to apply for the 
whole of Germany as this study provides data for only a circumscribed area 
(southern Bavaria) with characteristically small animal plants.  
There is a paucity of studies that show a countrywide prevalence in Germany 
and other countries. Additional nationwide surveys would be necessary to 
assess prevalence rates for resistant bacteria, as well as for potentially 
foodborne pathogens, to determine the risk of transmission from animals and 
their products to humans. This is necessary to provide a solid basis for taking 
effective and timely risk management decisions to ensure public health. 
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V.  SUMMARY 
 
To ensure food safety the idea of an integrated approach of surveillance “from 
farm to fork“ was established to enable the risk assessment and risk 
management on every level of the food chain. Pathogen prevalence 
monitoring is an essential part in detecting and evaluating a potential 
transmission of pathogens, particularly in primary production where 
transmission can occur via animals and/or their products. Furthermore, 
consumers are concerned about increasing reports of resistant bacteria, as a 
growing number of extended-spectrum β-lactamases have been identified in 
Enterobacteriaceae during the last few years. They were not only detected in 
humans, but also in a broad range of animal species and also in food.  
 
Therefore, the present study was conducted to determine first, the prevalence 
of ESBL E. coli and second, the prevalences of C. difficile, C. botulinum and Y. 
enterocolitica on dairy and beef cattle farms in the southern part of Bavaria. 
Fecal samples, boot swabs and dust samples were collected in a one-year 
period from summer 2011 to summer 2012. 
ESBL E.coli could be detected by selective culturing after enrichment in a total 
of 196 of 598 samples (32.8%) and originated from 39 (86.7%) of 45 farms. 
Samples obtained from mixed dairy and beef cattle farms were significantly 
more likely to harbor ESBL E. coli than samples from beef cattle farms 
(percentage of ESBL E. coli in fecal samples from mixed farms: 39.6%, in 
fecal samples from beef cattle farms: 18.9%; in boot swabs from mixed farms: 
51.1%, in boot swabs from beef cattle farms: 25.8%; in dust samples from 
mixed farms: 19.3%, in dust samples from beef cattle farms: 3.5%). The 
highest rates of ESBL E. coli on mixed farms could be detected in calves with 
56.2% of fecal samples being positive for ESBL E. coli followed by cows 
(41.1% of fecal samples) and beef cattle (21.4% of fecal samples). 
Furthermore, a total of 183 isolates (93.4%) of 196 ESBL E. coli positive 
strains harbored CTX-M genes, CTX-M group 1 being the most frequently 
found group. Forty six additional isolates contained ampC genes and five of 
the 46 isolates expressed a blaCMY-2 gene.    
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C. difficile genes were detected in 29 of 506 samples (5.7%), where 25 
samples originated from dairy farms and four from beef cattle farms. Toxin 
genes were identified in 17 samples showing the toxigenic profiles A+B+CDT-, 
A+B-CDT+, and A+B+CDT+. C. botulinum toxin genes could not be detected in 
fecal samples from cattle, but in one dust sample (0.8%) harboring toxin gene 
B. Y. enterocolitica genes were found in six of 382 fecal samples (1.6%) from 
three dairy farms and one beef cattle farm.  
This study reveals that ESBL E. coli are commonly found on Bavarian dairy 
and beef cattle farms, whereas C. difficile and Y. enterocolitica can only rarely 
be found. In contrast to previous studies C. botulinum could not be detected in 
fecal samples, but sporadically in dust samples from the cattle environment. 
These results lead to the conclusion that ESBL-producing bacteria can 
potentially be transferred to humans via animals or their products. However, 
there is still a paucity of studies giving evidence for such a transfer. 
Furthermore, the data suggest that, at least in Bavaria, cattle and their 
products may be a minor reservoir for transmitting C. difficile, C. botulinum and 
Y. enterocolitica to humans. 
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VI.  ZUSAMMENFASSUNG 
 
Prävalenz von Extended- Spectrum β- Laktamase- 
produzierenden Escherichia coli, toxinogenen Clostridium spp. 
und Yersinia enterocolitica in bayerischen Milch- und 
Mastrinderbeständen 
 
Um die Sicherheit der Lebensmittel zu gewährleisten wurde die Idee eines 
integrierten Ansatzes der Überwachung „from farm to fork“ aufgebaut, um auf 
jeder Ebene der Lebensmittelkette die Risikobewertung und das 
Risikomanagement zu ermöglichen. Das Prävalenzmonitoring von 
Pathogenen ist ein grundlegender Teil beim Nachweis und der Beurteilung 
einer potentiellen Übertragung von Krankheitserregern, vor allem in der 
Primärproduktion, wo die Übertragung über Tiere und/oder deren Produkte 
erfolgen kann. Weiterhin sind Konsumenten über zunehmende Berichte von 
resistenten Bakterien beunruhigt, da eine steigende Anzahl von Extended-
Spectrum β-Laktamasen in Enterobacteriaceae in den letzten Jahren nicht nur 
bei Menschen, sondern auch in einer Vielzahl von Tierarten und in 
Lebensmitteln nachgewiesen wurden.  
Die vorliegende Studie wurde daher durchgeführt, um zum Einen die 
Prävalenz von ESBL E. coli und zum Anderen die Prävalenzen von C. difficile, 
C. botulinum und Y. enterocolitica in Milch- und Mastrinderbetrieben in 
Südbayern zu ermitteln. Während eines Jahres, von Sommer 2011 bis 
Sommer 2012, wurden Kotproben, Sockentupfer, und Staubproben 
gesammelt. 
ESBL E. coli konnten nach Anreicherung auf selektiven Nährböden in 196 von 
598 (32,8%) Proben angezüchtet werden und stammten von 39 von 
insgesamt 45 (86,7%) Betrieben. Proben, die von kombinierten Milch- und 
Mastrinderbetrieben stammten, enthielten signifikant häufiger ESBL E.coli als 
Proben von reinen Mastrinderbetrieben (Prozent ESBL E. coli in Kotproben 
von Kombibetrieben: 39,6%, in Kotproben von Mastbetrieben: 18,9%; in 
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Sockentupfern von Kombibetrieben: 51,1%, in Sockentupfern von 
Mastbetrieben: 25,8%; in Staubproben von Kombibetrieben: 19,3%, in 
Staubproben von Mastbetrieben: 3,5%). Der größte Anteil an ESBL E. coli auf 
Kombibetrieben konnte bei Kälbern gefunden werden, mit 56,2% ESBL E. coli 
positiven Kotproben, gefolgt von den Kühen (41,1% der Kotproben) und 
Mastrindern (21,4% der Kotproben). Weiterhin enthielten 183 von 196 (93,4%) 
ESBL E. coli positiven Stämme CTX-M Gene, wobei CTX-M Gruppe 1 die am 
häufigsten vorgefundene Gruppe war. Weitere 46 Isolate enthielten ampC 
Gene, wobei fünf der 46 Isolate ein blaCMY-2 Gen exprimierten. 
 
Gene für C. difficile wurden in 29 von 506 Proben (5,7%) gefunden, wobei 25 
Proben von Milch- und vier von Mastrinderbetrieben stammten. Toxingene 
wurden in 17 Proben ermittelt und zeigten die Toxingenprofile A+B+CDT-, A+B-
CDT+, und A+B+CDT+. C. botulinum Toxingene konnten in den 
Rinderkotproben nicht nachgewiesen werden, jedoch in einer Staubprobe 
(0,8%), die Toxingen B enthielt. Gene von Y. enterocolitica wurden in sechs 
von 382 Kotproben (1,6%) von drei Milch- und einem Mastrinderbetrieb 
gefunden.  
Diese Studie zeigt, dass ESBL E. coli häufig auf bayerischen Milch- und 
Mastrinderbeständen gefunden wird, wohingegen C. difficile und Y. 
enterocolitica nur selten nachgewiesen werden können. Im Gegensatz zu 
vorangegangenen Studien konnte C. botulinum nicht in Kotproben 
nachgewiesen werden, aber vereinzelt in Staubproben aus der Umgebung der 
Rinder. Diese Ergebnisse führen zu dem Schluss, dass ESBL-Bildner 
potentiell über Tiere oder deren Produkte auf den Menschen übertragen 
werden können. Dennoch gibt es einen Mangel an Studien, die solch einen 
Transfer beweisen. Weiterhin weisen die Daten darauf hin, dass zumindest in 
Bayern Rinder und deren Produkte ein unbedeutendes Reservoir für die 
Übertragung von C. difficile, C. botulinum und Y. enterocolitica auf Menschen 
zu sein scheinen. 
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